Optimal surgical management for high-risk populations

Area of Science:

• Oncology
• Surgical Oncology
• Genetics

Background:

• Breast cancer comprises genetically distinct subtypes with varied treatment responses and failure patterns.
• High-risk patient groups, including young individuals, triple-negative breast cancer (TNBC) patients, and those with BRCA1/BRCA2 mutations, face increased risk of local recurrence.
• Optimal surgical management for these high-risk populations remains a subject of ongoing clinical questions.

Purpose of the Study:

• To evaluate the necessity and efficacy of more aggressive surgical interventions for specific high-risk breast cancer patient groups.
• To differentiate the optimal surgical approach based on intrinsic tumor biology and inherited genetic risk factors.

Main Methods:

• Review of current literature and clinical data concerning surgical treatment outcomes in high-risk breast cancer cohorts.
• Analysis of treatment response and failure patterns in relation to patient age, tumor subtype (e.g., TNBC), and genetic mutations (BRCA1/BRCA2).

Main Results:

• Mastectomy does not appear to mitigate the inferior outcomes associated with younger age or the triple-negative breast cancer subtype.
• For patients with inherited risk due to BRCA1/BRCA2 mutations, a more aggressive surgical approach might be considered.
• Factors such as patient age, estrogen receptor (ER) status, tumor stage, and personal preferences are crucial in surgical decision-making for inherited risk groups.

Conclusions:

• Aggressive surgical therapy, such as mastectomy, is not warranted for young or triple-negative breast cancer patients based on current evidence.
• Individualized surgical strategies are essential, particularly for patients with inherited predispositions, considering a multifactorial approach.
• Further research should focus on tailoring surgical management to specific breast cancer subtypes and genetic profiles to optimize patient outcomes.